Hugo R. Castro

Instituto do Câncer do Estado de São Paulo

1

h-index

1

Publications

3,175

Citations

Publications

1 shown

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok , Yi‐Long Wu , Iveta Kudaba +97 more

2019 The Lancet 3175 citations

Frequent Co-Authors

Tony Mok

Chinese University of Hong Kong

Yi‐Long Wu

Guangdong Provincial People's Hospital

Iveta Kudaba

Riga East University Hospital

Dariusz M. Kowalski

Université Toulouse III - Paul Sabatier

Byoung Chul Cho

Yonsei University

H.Z. Turna

Istanbul University

Researcher Info

h-index: 1
Publications: 1
Citations: 3,175
Institution: Instituto do Câncer do Estado de São Paulo

External Links

Google Scholar

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.